Clinical trial
Detection, Treatment and Survival of Pancreatic Cancer Recurrence in the Netherlands
NCT04605237 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection, Treatment and Survival of Pancreatic Cancer Recurrence in the Netherlands
- Lead sponsor
- UMC Utrecht
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2014
- Completion date
- July 1, 2023
- Enrollment
- 1,750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas cancer, pancreatic cancer, pancreatic ductal adenocarcinoma, pdac